APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Severe Asthma Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Severe Asthma Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174034900322 December 2025196 pages

Choose your research edition.

Industry ResearchSevere Asthma Treatment Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Severe Asthma Treatment Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Severe Asthma Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Severe Asthma Treatment Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Severe Asthma Treatment Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Severe Asthma Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Severe Asthma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Severe Asthma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Severe Asthma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Severe Asthma Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Severe Asthma Treatment include Teva Pharmaceutical, Suzhou Connect Biopharmaceuticals, Sanofi, Novartis, Roche, GlaxoSmithKline, AstraZeneca, Regeneron Pharmaceutical and Pieris Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Severe Asthma Treatment market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Severe Asthma Treatment and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Severe Asthma Treatment sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Severe Asthma Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Severe Asthma Treatment Segment by Company

Teva Pharmaceutical

Suzhou Connect Biopharmaceuticals

Sanofi

Novartis

Roche

GlaxoSmithKline

AstraZeneca

Regeneron Pharmaceutical

Pieris Pharma

Morphosys

Biosion

Avalo Therapeutics

AB Pharma

4D Pharma plc

Severe Asthma Treatment Segment by Type

lntravenous

Oral

Subcutaneous

lnhaled

Severe Asthma Treatment Segment by Application

Teenagers

Children

Adults

Severe Asthma Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Severe Asthma Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Severe Asthma Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Severe Asthma Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Severe Asthma Treatment market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Severe Asthma Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Severe Asthma Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Severe Asthma Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Severe Asthma Treatment Industry Trends Table 2. Severe Asthma Treatment Industry Drivers Table 3. Severe Asthma Treatment Industry Opportunities and Challenges Table 4. Severe Asthma Treatment Industry Restraints Table 5. Global Severe Asthma Treatment Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Severe Asthma Treatment Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Severe Asthma Treatment Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Severe Asthma Treatment Sales Market Share by Manufacturers Table 9. Global Severe Asthma Treatment Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Severe Asthma Treatment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Severe Asthma Treatment Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Severe Asthma Treatment Manufacturers, Product Type & Application Table 13. Global Severe Asthma Treatment Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Severe Asthma Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of lntravenous Table 17. Major Manufacturers of Oral Table 18. Major Manufacturers of Subcutaneous Table 19. Major Manufacturers of lnhaled Table 20. Global Severe Asthma Treatment Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Severe Asthma Treatment Sales by Type (2021-2026) & (k units) Table 22. Global Severe Asthma Treatment Sales by Type (2027-2032) & (k units) Table 23. Global Severe Asthma Treatment Sales Market Share by Type (2021-2026) Table 24. Global Severe Asthma Treatment Sales Market Share by Type (2027-2032) Table 25. Global Severe Asthma Treatment Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Severe Asthma Treatment Revenue by Type (2021-2026) & (k units) Table 27. Global Severe Asthma Treatment Revenue by Type (2027-2032) & (k units) Table 28. Global Severe Asthma Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Severe Asthma Treatment Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Teenagers Table 31. Major Manufacturers of Children Table 32. Major Manufacturers of Adults Table 33. Global Severe Asthma Treatment Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Severe Asthma Treatment Sales by Application (2021-2026) & (k units) Table 35. Global Severe Asthma Treatment Sales by Application (2027-2032) & (k units) Table 36. Global Severe Asthma Treatment Sales Market Share by Application (2021-2026) Table 37. Global Severe Asthma Treatment Sales Market Share by Application (2027-2032) Table 38. Global Severe Asthma Treatment Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Severe Asthma Treatment Revenue by Application (2021-2026) & (k units) Table 40. Global Severe Asthma Treatment Revenue by Application (2027-2032) & (k units) Table 41. Global Severe Asthma Treatment Revenue Market Share by Application (2021-2026) Table 42. Global Severe Asthma Treatment Revenue Market Share by Application (2027-2032) Table 43. Global Severe Asthma Treatment Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Severe Asthma Treatment Sales by Region (2021-2026) & (k units) Table 45. Global Severe Asthma Treatment Sales Market Share by Region (2021-2026) Table 46. Global Severe Asthma Treatment Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Severe Asthma Treatment Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Severe Asthma Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Severe Asthma Treatment Sales by Country (2021-2026) & (k units) Table 50. North America Severe Asthma Treatment Sales by Country (2027-2032) & (k units) Table 51. Europe Severe Asthma Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Severe Asthma Treatment Sales by Country (2021-2026) & (k units) Table 53. Europe Severe Asthma Treatment Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Severe Asthma Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Severe Asthma Treatment Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Severe Asthma Treatment Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Severe Asthma Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Severe Asthma Treatment Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Severe Asthma Treatment Sales by Country (2027-2032) & (k units) Table 60. Global Severe Asthma Treatment Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Severe Asthma Treatment Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Severe Asthma Treatment Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Severe Asthma Treatment Revenue Market Share by Region (2021-2026) Table 64. Global Severe Asthma Treatment Revenue Market Share by Region (2027-2032) Table 65. Teva Pharmaceutical Company Information Table 66. Teva Pharmaceutical Business Overview Table 67. Teva Pharmaceutical Severe Asthma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Teva Pharmaceutical Severe Asthma Treatment Product Portfolio Table 69. Teva Pharmaceutical Recent Development Table 70. Suzhou Connect Biopharmaceuticals Company Information Table 71. Suzhou Connect Biopharmaceuticals Business Overview Table 72. Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product Portfolio Table 74. Suzhou Connect Biopharmaceuticals Recent Development Table 75. Sanofi Company Information Table 76. Sanofi Business Overview Table 77. Sanofi Severe Asthma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Sanofi Severe Asthma Treatment Product Portfolio Table 79. Sanofi Recent Development Table 80. Novartis Company Information Table 81. Novartis Business Overview Table 82. Novartis Severe Asthma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Novartis Severe Asthma Treatment Product Portfolio Table 84. Novartis Recent Development Table 85. Roche Company Information Table 86. Roche Business Overview Table 87. Roche Severe Asthma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Roche Severe Asthma Treatment Product Portfolio Table 89. Roche Recent Development Table 90. GlaxoSmithKline Company Information Table 91. GlaxoSmithKline Business Overview Table 92. GlaxoSmithKline Severe Asthma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. GlaxoSmithKline Severe Asthma Treatment Product Portfolio Table 94. GlaxoSmithKline Recent Development Table 95. AstraZeneca Company Information Table 96. AstraZeneca Business Overview Table 97. AstraZeneca Severe Asthma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. AstraZeneca Severe Asthma Treatment Product Portfolio Table 99. AstraZeneca Recent Development Table 100. Regeneron Pharmaceutical Company Information Table 101. Regeneron Pharmaceutical Business Overview Table 102. Regeneron Pharmaceutical Severe Asthma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Regeneron Pharmaceutical Severe Asthma Treatment Product Portfolio Table 104. Regeneron Pharmaceutical Recent Development Table 105. Pieris Pharma Company Information Table 106. Pieris Pharma Business Overview Table 107. Pieris Pharma Severe Asthma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Pieris Pharma Severe Asthma Treatment Product Portfolio Table 109. Pieris Pharma Recent Development Table 110. Morphosys Company Information Table 111. Morphosys Business Overview Table 112. Morphosys Severe Asthma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Morphosys Severe Asthma Treatment Product Portfolio Table 114. Morphosys Recent Development Table 115. Biosion Company Information Table 116. Biosion Business Overview Table 117. Biosion Severe Asthma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Biosion Severe Asthma Treatment Product Portfolio Table 119. Biosion Recent Development Table 120. Avalo Therapeutics Company Information Table 121. Avalo Therapeutics Business Overview Table 122. Avalo Therapeutics Severe Asthma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Avalo Therapeutics Severe Asthma Treatment Product Portfolio Table 124. Avalo Therapeutics Recent Development Table 125. AB Pharma Company Information Table 126. AB Pharma Business Overview Table 127. AB Pharma Severe Asthma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. AB Pharma Severe Asthma Treatment Product Portfolio Table 129. AB Pharma Recent Development Table 130. 4D Pharma plc Company Information Table 131. 4D Pharma plc Business Overview Table 132. 4D Pharma plc Severe Asthma Treatment Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. 4D Pharma plc Severe Asthma Treatment Product Portfolio Table 134. 4D Pharma plc Recent Development Table 135. Key Raw Materials Table 136. Raw Materials Key Suppliers Table 137. Severe Asthma Treatment Distributors List Table 138. Severe Asthma Treatment Customers List Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Severe Asthma Treatment Product Image Figure 2. Global Severe Asthma Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Severe Asthma Treatment Market Size (2021-2032) & (US$ Million) Figure 4. Global Severe Asthma Treatment Sales (2021-2032) & (k units) Figure 5. Global Severe Asthma Treatment Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Severe Asthma Treatment Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. lntravenous Image Figure 9. Oral Image Figure 10. Subcutaneous Image Figure 11. lnhaled Image Figure 12. Global Severe Asthma Treatment Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Severe Asthma Treatment Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Severe Asthma Treatment Sales Market Share by Type (2021-2032) Figure 15. Global Severe Asthma Treatment Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Severe Asthma Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Severe Asthma Treatment Revenue Market Share by Type (2021-2032) Figure 18. Teenagers Image Figure 19. Children Image Figure 20. Adults Image Figure 21. Global Severe Asthma Treatment Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Severe Asthma Treatment Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Severe Asthma Treatment Sales Market Share by Application (2021-2032) Figure 24. Global Severe Asthma Treatment Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Severe Asthma Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Severe Asthma Treatment Revenue Market Share by Application (2021-2032) Figure 27. North America Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Severe Asthma Treatment Sales Market Share by Country (2021-2032) Figure 29. U.S. Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Severe Asthma Treatment Sales Market Share by Country (2021-2032) Figure 34. Germany Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Severe Asthma Treatment Sales Market Share by Country (2021-2032) Figure 41. China Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Severe Asthma Treatment Sales Market Share by Country (2021-2032) Figure 49. Brazil Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Severe Asthma Treatment Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Severe Asthma Treatment Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Severe Asthma Treatment Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Severe Asthma Treatment Revenue (2021-2032) & (US$ Million) Figure 60. North America Severe Asthma Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Severe Asthma Treatment Revenue (2021-2032) & (US$ Million) Figure 62. Europe Severe Asthma Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Severe Asthma Treatment Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Severe Asthma Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Severe Asthma Treatment Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Severe Asthma Treatment Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Severe Asthma Treatment Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Severe Asthma Treatment Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • lntravenous
  • Oral
  • Subcutaneous
  • lnhaled
Applications
  • Teenagers
  • Children
  • Adults
Companies covered
  • Teva Pharmaceutical
  • Suzhou Connect Biopharmaceuticals
  • Sanofi
  • Novartis
  • Roche
  • GlaxoSmithKline
  • AstraZeneca
  • Regeneron Pharmaceutical
  • Pieris Pharma
  • Morphosys
  • Biosion
  • Avalo Therapeutics
  • AB Pharma
  • 4D Pharma plc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Severe Asthma Treatment Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Severe Asthma Treatment Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Severe Asthma Treatment Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Severe Asthma Treatment Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Severe Asthma Treatment Market Dynamics
  1. 2.1 Severe Asthma Treatment Industry Trends
  2. 2.2 Severe Asthma Treatment Industry Drivers
  3. 2.3 Severe Asthma Treatment Industry Opportunities and Challenges
  4. 2.4 Severe Asthma Treatment Industry Restraints
3 Severe Asthma Treatment Market by Manufacturers
  1. 3.1 Global Severe Asthma Treatment Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Severe Asthma Treatment Sales by Manufacturers (2021-2026)
  3. 3.3 Global Severe Asthma Treatment Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Severe Asthma Treatment Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Severe Asthma Treatment Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Severe Asthma Treatment Manufacturers, Product Type & Application
  7. 3.7 Global Severe Asthma Treatment Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Severe Asthma Treatment Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Severe Asthma Treatment Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Severe Asthma Treatment Tier 1, Tier 2, and Tier 3
4 Severe Asthma Treatment Market by Type
  1. 4.1 Severe Asthma Treatment Type Introduction
  2. 4.1.1 lntravenous
  3. 4.1.2 Oral
  4. 4.1.3 Subcutaneous
  5. 4.1.4 lnhaled
  6. 4.2 Global Severe Asthma Treatment Sales by Type
  7. 4.2.1 Global Severe Asthma Treatment Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Severe Asthma Treatment Sales by Type (2021-2032)
  9. 4.2.3 Global Severe Asthma Treatment Sales Market Share by Type (2021-2032)
  10. 4.3 Global Severe Asthma Treatment Revenue by Type
  11. 4.3.1 Global Severe Asthma Treatment Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Severe Asthma Treatment Revenue by Type (2021-2032)
  13. 4.3.3 Global Severe Asthma Treatment Revenue Market Share by Type (2021-2032)
5 Severe Asthma Treatment Market by Application
  1. 5.1 Severe Asthma Treatment Application Introduction
  2. 5.1.1 Teenagers
  3. 5.1.2 Children
  4. 5.1.3 Adults
  5. 5.2 Global Severe Asthma Treatment Sales by Application
  6. 5.2.1 Global Severe Asthma Treatment Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Severe Asthma Treatment Sales by Application (2021-2032)
  8. 5.2.3 Global Severe Asthma Treatment Sales Market Share by Application (2021-2032)
  9. 5.3 Global Severe Asthma Treatment Revenue by Application
  10. 5.3.1 Global Severe Asthma Treatment Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Severe Asthma Treatment Revenue by Application (2021-2032)
  12. 5.3.3 Global Severe Asthma Treatment Revenue Market Share by Application (2021-2032)
6 Global Severe Asthma Treatment Sales by Region
  1. 6.1 Global Severe Asthma Treatment Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Severe Asthma Treatment Sales by Region (2021-2032)
  3. 6.2.1 Global Severe Asthma Treatment Sales by Region (2021-2026)
  4. 6.2.2 Global Severe Asthma Treatment Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Severe Asthma Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Severe Asthma Treatment Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Severe Asthma Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Severe Asthma Treatment Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Severe Asthma Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Severe Asthma Treatment Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Severe Asthma Treatment Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Severe Asthma Treatment Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Severe Asthma Treatment Revenue by Region
  1. 7.1 Global Severe Asthma Treatment Revenue by Region
  2. 7.1.1 Global Severe Asthma Treatment Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Severe Asthma Treatment Revenue by Region (2021-2026)
  4. 7.1.3 Global Severe Asthma Treatment Revenue by Region (2027-2032)
  5. 7.1.4 Global Severe Asthma Treatment Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Severe Asthma Treatment Revenue (2021-2032)
  8. 7.2.2 North America Severe Asthma Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Severe Asthma Treatment Revenue (2021-2032)
  11. 7.3.2 Europe Severe Asthma Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Severe Asthma Treatment Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Severe Asthma Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Severe Asthma Treatment Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Severe Asthma Treatment Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical
  2. 8.1.1 Teva Pharmaceutical Company Information
  3. 8.1.2 Teva Pharmaceutical Business Overview
  4. 8.1.3 Teva Pharmaceutical Severe Asthma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Severe Asthma Treatment Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Recent Developments
  7. 8.2 Suzhou Connect Biopharmaceuticals
  8. 8.2.1 Suzhou Connect Biopharmaceuticals Company Information
  9. 8.2.2 Suzhou Connect Biopharmaceuticals Business Overview
  10. 8.2.3 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Suzhou Connect Biopharmaceuticals Severe Asthma Treatment Product Portfolio
  12. 8.2.5 Suzhou Connect Biopharmaceuticals Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Severe Asthma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Severe Asthma Treatment Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Severe Asthma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Severe Asthma Treatment Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Roche
  26. 8.5.1 Roche Company Information
  27. 8.5.2 Roche Business Overview
  28. 8.5.3 Roche Severe Asthma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Roche Severe Asthma Treatment Product Portfolio
  30. 8.5.5 Roche Recent Developments
  31. 8.6 GlaxoSmithKline
  32. 8.6.1 GlaxoSmithKline Company Information
  33. 8.6.2 GlaxoSmithKline Business Overview
  34. 8.6.3 GlaxoSmithKline Severe Asthma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 GlaxoSmithKline Severe Asthma Treatment Product Portfolio
  36. 8.6.5 GlaxoSmithKline Recent Developments
  37. 8.7 AstraZeneca
  38. 8.7.1 AstraZeneca Company Information
  39. 8.7.2 AstraZeneca Business Overview
  40. 8.7.3 AstraZeneca Severe Asthma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 AstraZeneca Severe Asthma Treatment Product Portfolio
  42. 8.7.5 AstraZeneca Recent Developments
  43. 8.8 Regeneron Pharmaceutical
  44. 8.8.1 Regeneron Pharmaceutical Company Information
  45. 8.8.2 Regeneron Pharmaceutical Business Overview
  46. 8.8.3 Regeneron Pharmaceutical Severe Asthma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Regeneron Pharmaceutical Severe Asthma Treatment Product Portfolio
  48. 8.8.5 Regeneron Pharmaceutical Recent Developments
  49. 8.9 Pieris Pharma
  50. 8.9.1 Pieris Pharma Company Information
  51. 8.9.2 Pieris Pharma Business Overview
  52. 8.9.3 Pieris Pharma Severe Asthma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Pieris Pharma Severe Asthma Treatment Product Portfolio
  54. 8.9.5 Pieris Pharma Recent Developments
  55. 8.10 Morphosys
  56. 8.10.1 Morphosys Company Information
  57. 8.10.2 Morphosys Business Overview
  58. 8.10.3 Morphosys Severe Asthma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Morphosys Severe Asthma Treatment Product Portfolio
  60. 8.10.5 Morphosys Recent Developments
  61. 8.11 Biosion
  62. 8.11.1 Biosion Company Information
  63. 8.11.2 Biosion Business Overview
  64. 8.11.3 Biosion Severe Asthma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Biosion Severe Asthma Treatment Product Portfolio
  66. 8.11.5 Biosion Recent Developments
  67. 8.12 Avalo Therapeutics
  68. 8.12.1 Avalo Therapeutics Company Information
  69. 8.12.2 Avalo Therapeutics Business Overview
  70. 8.12.3 Avalo Therapeutics Severe Asthma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Avalo Therapeutics Severe Asthma Treatment Product Portfolio
  72. 8.12.5 Avalo Therapeutics Recent Developments
  73. 8.13 AB Pharma
  74. 8.13.1 AB Pharma Company Information
  75. 8.13.2 AB Pharma Business Overview
  76. 8.13.3 AB Pharma Severe Asthma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 AB Pharma Severe Asthma Treatment Product Portfolio
  78. 8.13.5 AB Pharma Recent Developments
  79. 8.14 4D Pharma plc
  80. 8.14.1 4D Pharma plc Company Information
  81. 8.14.2 4D Pharma plc Business Overview
  82. 8.14.3 4D Pharma plc Severe Asthma Treatment Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 4D Pharma plc Severe Asthma Treatment Product Portfolio
  84. 8.14.5 4D Pharma plc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Severe Asthma Treatment Value Chain Analysis
  2. 9.1.1 Severe Asthma Treatment Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Severe Asthma Treatment Production Mode & Process
  6. 9.2 Severe Asthma Treatment Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Severe Asthma Treatment Distributors
  9. 9.2.3 Severe Asthma Treatment Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst